Health ❯ Healthcare ❯ Cancer Research

Immunotherapy

Checkpoint Inhibitors Pembrolizumab Mathematical Modeling Immune Checkpoint Inhibitors Therapeutic Targets Glypican-3 Targeting PD-1 Blockade Tumor Immune Evasion T Cell Therapy Monoclonal Antibodies PD-1 Inhibitors Childhood Cancer Vaccines Antibody-Drug Conjugates Cancer Treatment

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

Next steps center on Phase 3 confirmation, with full data pending.

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC

Padcev and Keytruda Combo Extends Survival in Bladder Cancer Trial

GPC3-Targeted PET Tracer Detects Early Liver Cancer With Unmatched Accuracy